期刊文献+

胎盘生长因子在膀胱移行细胞癌中的表达及临床意义

The expression and clinical significance of PLGF in bladder transitional cell carcinoma
下载PDF
导出
摘要 目的探讨胎盘生长因子在膀胱移行细胞癌(BTCC)中的表达及其临床意义。方法采用免疫组织化学法,检测30例BTCC及10例正常膀胱粘膜组织胎盘生长因子的表达。结果胎盘生长因子(PLGF)在BTCC组织中的表达明显高于正常膀胱粘膜组织(56.7%/10%,P<0.05);胎盘生长因子在膀胱移行细胞癌G2、G3级组织中的表达明显高于G1级;胎盘生长因子在膀胱移行细胞癌T2~T4期中的表达明显高于Tis~T1期。PLGF在BTCC中男女两组间表达的阳性率分别为:52.6%、63.6%,无显著差异。结论随着膀胱移行细胞癌病理分级的升高,癌组织中PLGF的表达也随之增加。PLGF在浸润性膀胱癌中的表达明显高于非浸润性膀胱癌,并且无性别差异。 Objective To investigate the exepression and clinical significance of Placenta growth factor (PLGF) in bladder transitional cell carcinoma (BTCC). Methods PLGF Expression in 30 cases of BTCC and 10 cases of normal epithelium was detected by immunohistochemical assay. Results PLGF ex- pression in BTCC was higher than that in the normal epithelium. Moreover, PLGF expression in G2 and G3 tissues of BTCC was higher than that in G1 tissue. Compared with the stage of Tis - T1, the higher PLGF expression rate was shown in the stage of T2 - T4 of BTCC. Furthermore, there was no significant difference of PLGF expression in BTCC between men and women. Conlusion PLGF expression gradually increases with the development of BTCC pathological grading. PLGF expression in invasive BTCC is higher than that in non -invasive BTCC with no sigficant difference between men and women.
出处 《遵义医学院学报》 2012年第6期500-502,共3页 Journal of Zunyi Medical University
基金 遵义市科技局项目(NO:遵市科合社[2009]29)
关键词 胎盘生长因子 膀胱移行细胞癌 免疫组织化学法 placenta growth factor bladder transitional cell carcinoma immunohistochemical assay clincal diagnostic index
  • 相关文献

参考文献10

  • 1Fischer C,Jonckx B,Carmeliet P. Anti-PLGF inhibits growth VEGF (R)-inhibitor-resistant tumors without affecting healthy vessels[J].Cell,2007,(03):463-475.
  • 2Matsumoto K,Suzuki K,Koike H. Prognostic significance of plasma placental growth factor levels in renal cell cancer:an association with clinical characteristics and vascular endothelial growth factor levels[J].Anticancer Research,2006,(06):4953-4958.
  • 3Parr C,Watkins G,Boulton M. Placenta growth factor is o-verexpressed and has prognostic value in human breast cancer[J].Eur J Ca-ncer,2005,(18):2819-2827.
  • 4Berse B,Brown L F,Van deWater L. Vascular permeability factor (vascular endothelial growth factor) gene is exressed differentially in normal tissues,macrophages and tumors[J].Molecular Biology of the Cell,1992.1237-1245.
  • 5梁培禾,靳风烁,张克勤,聂志林,叶锦.膀胱移行细胞癌VEGFR-2表达与血管生成的研究[J].第三军医大学学报,2006,28(10):1095-1097. 被引量:2
  • 6Vuorela P,Hatva E,Lymboussaki A. Expression of vascular en-dothelial growth factor and placenta growth factor in human placenta[J].Biology of Reproduction,1997,(02):489-494.
  • 7Clark D E,Smith S K,Licence D. Comparison of expression patterns for placenta growth factor,vascular endothelial growth factor(VEGF),VEGF-2B and VEGF-2C in the human placenta throughout gestation[J].J E-Ndocrinol,1998,(03):459-467.
  • 8Kodama J,Seki N,Tokumo K. Placenta growth factor is abundantly expressed in human cervical squamous cell carcinoma[J].European Journal of Gynaecological Oncology,1997,(06):508-410.
  • 9Donnini S,Machein M R,Plate KH. Expression and localization of placenta growth factor and PlGF receptors in human meningiomas[J].Journal of Pathology,1999,(01):66-71.
  • 10Adini A,Kornaga T,Firoozbakht F. Placental growth factor is asurvival factor for tumor endothelial cells andmacrophages[J].Cancer Research,2002,(10):2749-2752.

二级参考文献13

  • 1杨绍波,孔垂泽.血管内皮生长因子受体在肾细胞癌组织中的表达[J].中国医科大学学报,2004,33(4):352-353. 被引量:2
  • 2SHARMA S,SHARMA M C,SARKAR C.Morphology of angiogenesis in human cancer:a conceptual overview,histoprognostic perspective and significance of neoangiogenesis[J].Histopathology,2005,46(5):481 -489.
  • 3BOEHM T,FOLKMAN J,BROWDER T,et al.Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance[J].Nature,1997,390(6658):404 -407.
  • 4RAK J,YU J L.Oncogenes and tumor angiogenesis:the question of vascular "supply" and vascular "demand"[J].Semin Cancer Biol,2004,14(2):93-104.
  • 5NYBERG P,XIE L,KALLURI R.Endogenous inhibitors of angiogenesis[J].Cancer Res,2005,65 (10):3967-3979.
  • 6FERRARA N.VEGF and the quest for tumour angiogenesis factors[J].Nat Rev Cancer,2002,2(10):795 -803.
  • 7HEROLD-MENDE C,STEINER H H,ANDL T,et al.Expression and functional significance of vascular endothelial growth factor receptors in human tumor cells[J].Lab Invest,1999,79(12):1573 -1582.
  • 8SINGHAL S,VACHANI A,ANTIN-OZERKIS D,et al.Prognostic implications of cell cycle,apoptosis,and angiogenesis biomarkers in non-small cell lung cancer:a review[J].Clin Cancer Res,2005,11(11):3974-3986.
  • 9RELF M,LEJEUNE S,SCOTT P A,et al.Expression of the angiogenic factors vascular endothelial cell growth factor,acidic and basic fibroblast growth factor,tumor growth factor beta-1,platelet-derived endothelial cell growth factor,placenta growth factor,and pleiotrophin in human primary breast cancer and its relation to angiogenesis[J].Cancer Res,1997,57(5):963 -969.
  • 10YU J L,RAK J W,CARMELIET P,et al.Heterogeneous vascular dependence of tumor cell populations[J].Am J Pathol,2001,158(4):1325-1334.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部